Toronto, Canada, Aug. 12, 2021 (GLOBE NEWSWIRE) — As we all know, the evolving legalization of medical and recreational cannabis in the United States and Canada is taking us into uncharted territory. As more laws allow the use of this drug, it is well-worth considering how this will impact the safety of drivers, including whether our current methods of testing for THC (tetrahydrocannabinol, the compound largely responsible for the high that marijuana users experience) are really as fair and relevant as we need them to be. This is no small issue, as studies are revealing that drug-impaired driving is growing in both countries.
Here, then, is the question: when a law enforcement officer at the scene of a crash administers a THC blood-test to see if a driver is impaired, will that test provide an accurate picture of the driver’s impairment? The answer – that we are, in fact, relying on an outdated form of testing that is not always accurate – should concern anyone who cares about keeping drivers safe. It concerns the team at Cannabix Technologies Inc. (CSE: BLO, OTC Pink: BLOZF), a Canadian company that is developing marijuana breathalyzer technology, and they believe their innovations will help law enforcement officers detect THC-impairment of drivers, ultimately making it easier to prosecute offenders.
The Dangers All Drivers on the Road Face
As more legislation is passed that allows the use of medical and recreational cannabis in North America, the instances of drug-impaired driving increase as well. The studies done by the Insurance Institute for Highway Safety (IIHS) and the Highway Loss Data Institute (HLDI) both found that when recreational marijuana use and retail sales were legalized in California, Colorado, Nevada, Oregon, and Washington, those states saw a spike in automobile crashes. Another study by the AAA Foundation for Traffic Safety states that